Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

30 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed a media release dated September 30, 2021 titled ‘Glenmark receives marketing approval for Ryaltris, an innovative combination nasal spray, in 13 countries across the EU and UK’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..